STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G

MOR2 Schedule 13G filing by T. Rowe Price Investment Management

T. Rowe Price Investment Management reported beneficial ownership of 6.4M shares, representing 4.3% of MORPHOSYS AG ADR in this filing.

FiledFeb 14, 2024
Ownership dateDec 31, 2023
Reported shares6.4M
Reported ownership4.3%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 3.1M
Shared voting power 0
Sole dispositive power 9.1M
Shared dispositive power 0
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
T. Rowe Price Investment Management
CIK
CIK0001897612
Accession
0001897612-24-001302
Form
Schedule 13G
Open SEC filing View MOR2 ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →